The effect of statin therapy on heart failure events: a collaborative meta-analysis of unpublished data from major...

Area of Science:

• Cardiovascular Medicine
• Pharmacology
• Clinical Trials

Background:

• The impact of statin therapy on heart failure (HF) hospitalization and mortality remains incompletely understood.
• Statins are widely used for cardiovascular disease prevention, necessitating clarity on their effects on HF outcomes.

Purpose of the Study:

• To investigate the efficacy of statins in reducing major adverse heart failure events.
• To determine if statins decrease the risk of HF hospitalization and HF-related death.

Main Methods:

• A meta-analysis of randomized controlled statin trials (1994-2014) was conducted, including primary and secondary prevention studies with over 1000 participants and >1 year follow-up.
• Data from adverse event reports were obtained from collaborating trialists.
• Outcomes included non-fatal HF hospitalization, HF death, and a composite endpoint. Fixed-effects meta-analyses were used to calculate risk ratios (RR).

Main Results:

• The meta-analysis included up to 17 trials with 132,538 participants.
• Statin therapy significantly reduced non-fatal HF hospitalizations (RR 0.90, 95% CI 0.84-0.97) and the composite HF outcome (RR 0.92, 95% CI 0.85-0.99).
• No significant reduction was observed for HF death (RR 0.97, 95% CI 0.80-1.17).

Conclusions:

• Statins offer a modest benefit in reducing the risk of non-fatal heart failure hospitalization.
• A composite outcome of non-fatal HF hospitalization or HF death was also reduced by statins.
• The risk reduction for HF hospitalization was consistent regardless of whether a myocardial infarction (MI) preceded the event.